According to the latest report by IMARC Group, titled “Structural Heart Imaging Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” offers a comprehensive analysis of the industry, which comprises insights on the global structural heart imaging market growth. The report also includes competitor and regional analysis, and contemporary advancements in the market.

The global structural heart imaging market size reached a value of US$ 16.2 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 30.4 Billion by 2027 exhibiting a CAGR of 10.60% during 2022-2027.

Structural heart imaging (SHI) is an advanced method used to screen and examine the heart at the molecular level. It uses magnetic resonance imaging (MRI) with high tesla capacity and high-resolution cameras to perform structural heart imaging. SHI relies on light reflection to produce an image of the internal component and create a 2-dimensional (2D) cross-section interpretation for an accurate diagnosis. It helps medical professionals carry out various operative procedures, such as detecting the pathways and blockages for insertion by reducing the risks of interruption. As a result, SHI is gaining immense traction across the healthcare industry.

Request a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/structural-heart-imaging-market/requestsample

Structural Heart Imaging Market Trends and Drivers:

The global structural heart imaging market is primarily driven by the rising incidences of congenital heart diseases (CHDs) and lifestyle-induced ailments, such as high blood pressure, obesity, and diabetes. Moreover, there has been a rise in the use of SHI to diagnose cardiovascular disorders using high-resolution, precise cameras and sensors.

In line with this, the surging awareness among patients about the availability of cardiac care is positively influencing market growth. Additionally, recent product innovations, such as the introduction of transcatheter aortic valve replacement (TAVR) to perform angioplasty and ensure faster patient recovery post-surgery, have catalyzed market growth.

Furthermore, the implementation of various favorable government initiatives focusing on improving the healthcare infrastructure is contributing to market growth. Other factors, including ongoing research and development (R&D) activities, rising health consciousness, and technological advancements, are also anticipated to propel the market growth.

Global Structural Heart Imaging Market 2022-2027 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Structural Heart Imaging Companies:

Abbott Laboratories, Boston Scientific Corporation, Circle Cardiovascular Imaging Inc., Edwards Lifesciences Corporation, Integer Holdings Corporation, Koninklijke Philips N.V., Lepu Medical Technology (Beijing) Co. Ltd., LivaNova PLC, Medtronic plc, Pie Medical Imaging B.V. and Siemens Healthcare GmbH.

The report has segmented the market on the basis of region, imaging modality, procedure type, application and end user.

Breakup by Imaging Modality:

  • Echocardiogram
  • Angiogram
  • CT
  • MRI

Breakup by Procedure Type:

  • Transcatheter Aortic Valve Replacement (TAVR)  
  • Surgical Aortic Valve Replacement (SAVR)  
  • Transcatheter Mitral Valve Repair (TMVR)  
  • Left Atrial Appendage Closure (LAAC)
  • Annuloplasty  
  • Valvuloplasty
  • Others

Breakup by Application:

  • Diagnosis
  • Surgery

Breakup by End User:

  • Hospitals  
  • Specialty Clinics  
  • Cardiac Centers  
  • Diagnostic Centers  
  • Ambulatory Surgical Centers  
  • Catheterization Laboratories  
  • Others

Breakup by Region:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa

 Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=5127&flag=C

If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

 Key highlights of the report:

  • Market Performance (2016-2021)
  • Market Outlook (2022- 2027)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800